SkylineDx in collaboration with the Mayo Clinic published yesterday its first study describing a diagnostic test that could reduce up to 42% of surgical interventions used to diagnose patients with melanoma (skin cancer).
Archive | Health Professionals
Skin Cancer Test Reduces Need for Surgery
Posted in Melanoma News, Health Professionals, Of Interest
Mouse models and patient data suggest potential biomarker for immunotherapy response in melanoma
CCR scientists have identified a molecular signature that could help clinicians assess whether someone with melanoma is likely to benefit from immunotherapy. The discovery, reported April 13, 2020, in Nature Medicine, was made using four genetically engineered mouse models of the deadly skin cancer.
Posted in Melanoma News, Health Professionals, Of Interest
Korean Patients With Parkinson Disease May Have a Greater Risk of Skin Cancer
Korean patients with Parkinson disease (PD) were found to be at greater risk of developing skin cancer, with male and older populations considered higher-risk groups, according to study findings published this week in the Journal of the European Academy of Dermatology and Venereology.
Posted in Melanoma News, Health Professionals, Of Interest
Model Could Help Identify Who May Respond to Checkpoint Inhibition in Melanoma
The combination of radiomics and a blood marker-based prediction model may help to distinguish pseudoprogression from true progressive disease among patients with metastatic melanoma being treated with immune checkpoint inhibition, according to the results of a recent study.
Posted in Melanoma News, Health Professionals, Of Interest
